We recently published a list of Here’s What Fueled These 10 Firms’ Surge. In this article, we are going to take a look at ...

Google’s chief health officer Karen DeSalvo announced she will retire this summer. DeSalvo, who likes to introduce herself as ...

Hims & Hers Health, Inc.'s subscriber growth, Novo Nordisk partnership, and FDA pill approval could boost financials. Click ...

Telehealth company Hims & Hers reported first-quarter results late Monday that beat Wall Street estimates. But parts of the ...

Hims & Hers stock has risen by 20% after announcing a partnership to sell the popular weight-loss drug Wegovy.

Hims & Hers Health, Inc.'s Q1 results show 111% growth, yet shares fell 8%. Click for a look at the impact of drug access, ...

The Chicago-based former options trader, who started MWS in 2003 as a side business until kicking it off fully in 2012, oversees $157 million for high net-wealth clients. He said the firm's ...

LCGC EAB member Paul Ferguson has been named a professor by special appointment at the Faculty of Science at the University ...

The company reported adjusted earnings per share of $0.28 on revenue of $586 million – a significant rise compared to last ...

Ford's First-Quarter Profit Drops 64%; Suspends Outlook Tariff-related uncertainty led the company to withdraw its profit forecast for the year. OpenAI Abandons Planned For-Profit Conversion The maker ...

Hims & Hers Health (HIMS) stock is getting attention from options bulls after beating first-quarter expectations ...

Hims & Hers Health (NYSE:HIMS) reported a strong financial performance for Q1 2025, with revenue reaching $586 million, ...